MedTrace Logo

Alkagin Paste in the Prevention of Radiation Dermatitis

NCT01408407 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2026-05-14

No results posted yet for this study

Summary

The purpose of this study is to determine whether Alkagin paste is effective at preventing radiodermatitis in patients receiving external beam radiation therapy to the perineal area.

Conditions

  • Anus Neoplasms
  • Rectal Neoplasms
  • Urogenital Neoplasms

Interventions

OTHER

Aveeno cream

Apply cream on irradiated area twice a day

OTHER

Alkagin paste

Apply Alkagin paste three times a day.

Sponsors & Collaborators

  • Avario Healthcare Inc.

    collaborator INDUSTRY

  • Sir Mortimer B. Davis - Jewish General Hospital

    lead OTHER

Principal Investigators

  • Te Vuong, MD · Jewish General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2014-05-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01408407 on ClinicalTrials.gov